UBR5 antagonizes DNA damage to enhance the doxorubicin -resistance of triple negative breast cancer by p38 signaling
{{output}}
Background: Triple negative breast cancer (TNBC) is characterized by aggressive behavior and limited treatment options, with chemotherapy resistance posing a significant clinical challenge. UBR5, an E3 ubiquitin ligase, has been ... ...
